Correlation Between Inozyme Pharma and Chimerix
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Chimerix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Chimerix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Chimerix, you can compare the effects of market volatilities on Inozyme Pharma and Chimerix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Chimerix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Chimerix.
Diversification Opportunities for Inozyme Pharma and Chimerix
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Inozyme and Chimerix is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Chimerix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chimerix and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Chimerix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chimerix has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Chimerix go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Chimerix
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Chimerix. In addition to that, Inozyme Pharma is 2.43 times more volatile than Chimerix. It trades about -0.29 of its total potential returns per unit of risk. Chimerix is currently generating about 0.17 per unit of volatility. If you would invest 366.00 in Chimerix on November 8, 2024 and sell it today you would earn a total of 46.00 from holding Chimerix or generate 12.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Chimerix
Performance |
| Timeline |
| Inozyme Pharma |
| Chimerix |
Inozyme Pharma and Chimerix Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Chimerix
The main advantage of trading using opposite Inozyme Pharma and Chimerix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Chimerix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chimerix will offset losses from the drop in Chimerix's long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Chimerix vs. Assembly Biosciences | Chimerix vs. Spero Therapeutics | Chimerix vs. Achilles Therapeutics PLC | Chimerix vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |